Research
Hormonal
GLP-1RA-induced weight loss would lead to a marked decrease in cancer cases over 10 years in adults.
Implementing GLP-1RA treatments could significantly reduce cancer incidence in obese populations.
StrongSupportsmedium confidence
Our simulation within a closed cohort indicated that GLP-1RA-induced weight loss would lead to a marked decrease in cancer cases over 10 years in adults.
Why this rating
Based on the simulation model described in the abstract.
Source
Impact of GLP-1 receptor agonist-induced weight loss on 22 cancers in the next ten years using a Markov state-transition model – A UK weight and wellness cancer landscape analysis
Jiawen Dong et al. · Cancer Epidemiology · 2025
otherCited 3×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →